NU 9056
目录号 : GC11972
NU 9056 是一种有效且选择性的 Tip60 (KAT5) 组蛋白乙酰转移酶抑制剂，浓度为 2 µM。 NU 9056 对 Tip60 的选择性比 PCAF、p300 和 GCN5 高 16 倍以上。 NU 9056 诱导前列腺癌细胞凋亡。
Cas No.:1450644-28-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Selective KAT5 (Tip60) histone acetyltransferase inhibitor (IC50 values are < 2, 60, 36, and >100 μM for KAT5, p300, pCAF and GCN5, respectively). Inhibits protein acetylation in prostate cancer cell lines and blocks DNA damage response. Decreases proliferation of LNCaP cells; induces apoptosis via caspase activation.
| Kinase experiment [1]: | |
|
Specificity for Tip60 Acetyltransferase |
NU9056 was tested for in vitro activity against a panel of recombinant HAT enzymes, including p300, PCAF and GCN5, to determine whether it shows greater specificity towards Tip60. A number of compounds were found to inhibit the activity of Tip60 at low micromolar concentrations. However, specificity towards Tip60 over other HAT enzymes tested was found to be greatest with compound 7 (NU9056) as shown in Table 1 (16.5-, 29- and .50-fold for selectivity for Tip60 over PCAF, p300 and GCN5, respectively). |
| Cell experiment [1]: | |
|
Cell lines |
LNCaP cells, PC3 cells, LNCaP-CdxR and CWR22rv1 cells |
|
Preparation method |
Limited solubility. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
|
Reacting condition |
2.5, 5, 10, 20, and 40 μM; 24, 48, 72 and 96 h |
|
Applications |
In LNCaP cells, NU9056 decreased levels of acetylated histone H4K16, H3K14 and H4K8, targets for Tip60-mediated acetylation. NU9056 inhibited cell growth with GI50 values of 24 μM and 27 μM for LNCaP and PC3 cells, respectively. LNCaP-CdxR and CWR22rv1 cells showed significantly greater sensitivity to NU9056 than the parental LNCaP cell line with GI50 values of 12 μM and 7.5 μM, respectively. The most sensitive cell line CWR22rv1 actually expressed the most Tip60. Treatment with NU9056 (24 μM) for 24h significantly reduced colony forming ability of LNCaP cells. In LNCaP cells, NU9056 also resulted in both caspase 3 and caspase 9 activation in a time- and concentration-dependent way, and induced apoptosis. |
|
References: [1] Coffey K1, Blackburn TJ, Cook S, et al. Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer. PLoS One. 2012;7(10):e45539. |
|
| Cas No. | 1450644-28-6 | SDF | |
| 化学名 | 1,2-di(isothiazol-5-yl)disulfane | ||
| Canonical SMILES | C1(SSC2=CC=NS2)=CC=NS1 | ||
| 分子式 | C6H4N2S4 | 分子量 | 232.37 |
| 溶解度 | <10mg/ml in DMSO | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 4.3035 mL | 21.5174 mL | 43.0348 mL |
| 5 mM | 0.8607 mL | 4.3035 mL | 8.607 mL |
| 10 mM | 0.4303 mL | 2.1517 mL | 4.3035 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet